Published in Autoimmun Rev on June 25, 2008
Probiotics and immunity. J Gastroenterol (2009) 1.79
Cellular functions of tissue transglutaminase. Int Rev Cell Mol Biol (2012) 1.27
Novel immune response to gluten in individuals with schizophrenia. Schizophr Res (2009) 1.16
Celiac disease in the elderly. Gastroenterol Clin North Am (2009) 0.95
PPAR signaling pathway and cancer-related proteins are involved in celiac disease-associated tissue damage. Mol Med (2010) 0.94
Markers of Celiac Disease and Gluten Sensitivity in Children with Autism. PLoS One (2013) 0.90
Immune development and intestinal microbiota in celiac disease. Clin Dev Immunol (2012) 0.90
Application of dairy proteins as technological and nutritional improvers of calcium-supplemented gluten-free bread. Nutrients (2013) 0.85
Lack of serologic evidence to link IgA nephropathy with celiac disease or immune reactivity to gluten. PLoS One (2014) 0.83
The Interaction among Microbiota, Immunity, and Genetic and Dietary Factors Is the Condicio Sine Qua Non Celiac Disease Can Develop. J Immunol Res (2015) 0.83
Specific nongluten proteins of wheat are novel target antigens in celiac disease humoral response. J Proteome Res (2014) 0.79
Celiac sprue: a unique autoimmune disorder. Expert Rev Clin Immunol (2009) 0.78
Elderly Onset Celiac Disease: A Narrative Review. Clin Med Insights Gastroenterol (2016) 0.78
Gastrointestinal-associated autoantibodies in different autoimmune diseases. Am J Clin Exp Immunol (2012) 0.77
Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients. Nutrients (2013) 0.77
Genome-wide genetic and transcriptomic investigation of variation in antibody response to dietary antigens. Genet Epidemiol (2014) 0.77
Involvement of heat shock proteins in gluten-sensitive enteropathy. World J Gastroenterol (2014) 0.76
Quantitative image analysis of celiac disease. World J Gastroenterol (2015) 0.76
Validation of the Turkish version of the Celiac Disease Questionnaire (CDQ). Health Qual Life Outcomes (2015) 0.75
Immunopathogenesis and therapeutic approaches in pediatric celiac disease. Expert Rev Clin Immunol (2016) 0.75
Gluten Sensitivity among Egyptian Infants with Congenital Heart Disease. Open Access Maced J Med Sci (2017) 0.75
Emerging analytical methods to determine gluten markers in processed foods--method development in support of standard setting. Anal Bioanal Chem (2009) 0.75
Phenotypical characterization of the peripheral blood T cells in patients with celiac disease: does it differentiate suspicious celiac disease cases? Gastroenterol Hepatol Bed Bench (2015) 0.75
Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun (2010) 2.50
Serologic markers of Lyme disease in children with autism. JAMA (2013) 1.67
Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol Psychiatry (2010) 1.27
Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome. Clin Immunol (2011) 1.18
Novel immune response to gluten in individuals with schizophrenia. Schizophr Res (2009) 1.16
Neurological complications of celiac disease and autoimmune mechanisms: a prospective study. J Neuroimmunol (2008) 1.13
Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome. Clin Vaccine Immunol (2011) 1.09
Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr Res (2012) 1.01
Non-celiac gluten sensitivity. Gastrointest Endosc Clin N Am (2012) 0.99
Markers of gluten sensitivity and celiac disease in bipolar disorder. Bipolar Disord (2011) 0.97
Anti-ganglioside antibodies in idiopathic and hereditary cerebellar degeneration. Neurology (2003) 0.94
Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia. Neurobiol Dis (2012) 0.92
Two color RNA intercalating probe for cell imaging applications. J Am Chem Soc (2008) 0.91
Markers of Celiac Disease and Gluten Sensitivity in Children with Autism. PLoS One (2013) 0.90
Neurologic complications of celiac disease. J Clin Neuromuscul Dis (2004) 0.87
Anti-gluten immune response following Toxoplasma gondii infection in mice. PLoS One (2012) 0.86
Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder. Bipolar Disord (2013) 0.85
Synthesis and photophysical properties of thioglycosylated chlorins, isobacteriochlorins, and bacteriochlorins for bioimaging and diagnostics. Bioconjug Chem (2010) 0.83
Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits. J Neuroimmunol (2012) 0.83
Synthesis and photophysics of an octathioglycosylated zinc(II) phthalocyanine. Tetrahedron Lett (2011) 0.82
High-dose cyclophosphamide without stem cell rescue for refractory multifocal motor neuropathy. Muscle Nerve (2006) 0.80
Specific nongluten proteins of wheat are novel target antigens in celiac disease humoral response. J Proteome Res (2014) 0.79
A covalently linked phenanthridine-ruthenium(II) complex as a RNA probe. Chem Commun (Camb) (2009) 0.78
Genome-wide genetic and transcriptomic investigation of variation in antibody response to dietary antigens. Genet Epidemiol (2014) 0.77
Anti-heparan sulfate antibodies in neurological disease. Muscle Nerve (2002) 0.75
Lack of association between autism and anti-GM1 ganglioside antibody. Neurology (2013) 0.75
Autism and Lyme disease--reply. JAMA (2013) 0.75
Novel loss-of-function mutation of the HINT1 gene in a patient with distal motor axonal neuropathy without neuromyotonia. Muscle Nerve (2015) 0.75
Comment on diagnosis of unilateral trapezius muscle palsy: 54 cases. Muscle Nerve (2017) 0.75
Long-term plasma exchange in pediatric CIDP. J Clin Apher (2015) 0.75
Different nerve ultrasound patterns in Charcot-Marie-Tooth types and HNPP. Muscle Nerve (2017) 0.75
Anti-ganglioside autoantibodies in type 1 diabetes. Muscle Nerve (2010) 0.75
Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial. Br J Haematol (2017) 0.75
Neuropathy and cognitive impairment following vaccination with the OspA protein of Borrelia burgdorferi. J Peripher Nerv Syst (2004) 0.75